Survival analysis between patients with invasive ductal and invasive lobular breast cancer
- First Online:
Differences in overall survival (OS) and disease-free survival (DFS) between patients with invasive ductal (IDC) and invasive lobular breast cancer (ILC) are controversial.
The study population was selected from a database of 5,689 female patients with invasive breast cancer. In order to focus on the impact of tumour histology, all primary metastatic patients and patients with adjuvant chemotherapy or anti-hormonal treatment were excluded. Only patients with pure invasive lobular and invasive ductal histology were included.
Multivariate survival analyses of 2,058 eligible patients confirmed tumour histology as an independent prognostic factor for OS in invasive breast cancer (p = 0.046) but not for DFS (p = 0.599). Kaplan–Meier survival analysis of OS between IDC and ILC patients showed a statistically significantly better OS for patients with ILC (p = 0.0302). DFS was not statistically different (p = 0.6659) between IDC and ILC. Univariate survival analyses of tumour size, tumour grading and nodal status in our study population were highly statistically significant for OS and DFS (p < 0.0000).
Patients in our study population with ILC have significantly better OS than patients with IDC. Differences in DFS are not statistically significant.
KeywordsBreast cancer Ductal Lobular Survival
- 3.Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Farante G et al (1990) Conservative treatment of early breast cancer, long-term results of 1,232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 221:250–259Google Scholar
- 4.Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P (1996) Infiltrating lobular carcinoma of the breast clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77(1):113–120PubMedCrossRefGoogle Scholar
- 6.Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G et al (2002) Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 95(12):2455–2464PubMedCrossRefGoogle Scholar
- 10.Korkolis DP, Tsoli E, Fouskakis D, Yiotis J, Koullias GJ, Giannapopoulos D, Papalambros E, Nikiteas NI, Spiliopoulou CA, Patsouris E, Asimacopoulos P, Gorgoulis VG (2004) Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer. Anticancer Res 24(3b):2061–2068Google Scholar
- 19.Santiago RJ, Harris EE, Quin L, Hwang WT, Solin LJ (2005) Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer 103(12):2447–2454PubMedCrossRefGoogle Scholar
- 21.du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JF, Blamey RW (1992) An evaluation of difference in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 17:251–257Google Scholar
- 23.Peiro G, Bornstein BA, Connolly JL, Gelman R, Heteledekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59:49–54PubMedCrossRefGoogle Scholar
- 27.Jalava P, Kuopio T, Huovinen R, Laine J, Collan Y (2005) Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints. Anticancer Res 25(3c):35–42Google Scholar
- 31.Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. Am J Roentgenol 161:957–960Google Scholar